Preparation and application of Epstein-Barr virus genome-wide genechip
Wei-yi FANG; Wen-ling ZHENG; Wen-li MA; Zhen LIU; Xin LI; Kai-tai YAO.
Journal of Southern Medical University
; (12): 1812-1815, 2009.
ArtÃculo en Zh | WPRIM | ID: wpr-336078
Documentos relacionados
Deep Learning Fuzzy Inference: An Interpretable Model for Detecting Indirect Immunofluorescence Patterns Associated with Nasopharyngeal Cancer.
Prognostic significance of circulating Epstein-Barr virus DNA in pulmonary lymphoepithelioma-like carcinoma: A meta-analysis and validation study.
Meta-analysis of Epstein-Barr virus genomes in Southern Chinese identifies genetic variants and high risk viral lineage associated with nasopharyngeal carcinoma.
A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients.
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect.
The immune escape mechanism of nasopharyngeal carcinoma.
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.
EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation.
Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives.